Congenital Glaucoma in Patients with Neonatal Diabetes and Congenital Hypothyroidism (NDH) Syndrome

Introduction

Neonatal diabetes and congenital hypothyroidism (NDH) syndrome is a rare condition caused by autosomal recessive mutations in the GLI-similar 3 (GLIS3) gene [1]. The human GLIS3 gene is located on chromosome 9p24.2 and encodes the Krüppel-like zinc finger transcription factor GLIS3 that is expressed during early embryogenesis [2]. It is implicated in the development of many organs, including the pancreas, kidneys, and eyes [2]. NDH syndrome was initially described in 2003, and the underlying GLIS3 mutations were identified in 2006 [3]. Since then, about 20 cases of NDH syndrome have been reported, with considerable phenotypic variability [1]. Although some affected individuals have died in early childhood, there are case reports of patients who survived into adulthood [4].

Apart from neonatal diabetes and congenital hypothyroidism, reported patients suffered from intrauterine growth retardation, developmental delay, hearing disorder, cardiac disorders, anaemia, cholestasis, liver fibrosis, megalocornea or glaucoma [4].

A recent case series involving 12 patients with NDH syndrome reported that intrauterine growth retardation and developmental delay were consistent features across all cases [5]. Nine of these 12 patients were born to parents who were first cousins. Notably, only 4 out of the 12 patients were diagnosed with congenital glaucoma (CG), suggesting variability in ocular manifestations [5].

To date, no specific exon of the GLIS3 gene has been conclusively associated with the development of CG in NDH syndrome, underscoring the need for further investigations [5]. We present the case of two cousins, each born to parents who were first cousins. The parents of one child were siblings of the parents of the other.

Publikationsverlauf

Eingereicht: 25. Mai 2025

Angenommen: 20. August 2025

Artikel online veröffentlicht:
17. Oktober 2025

• References

• 1 Splittstoesser V, Vollbach H, Plamper M. et al. Case Report: Extended Clinical Spectrum of the Neonatal Diabetes With Congenital Hypothyroidism Syndrome. Front Endocrinol (Lausanne) 2021; 12: 665336
• 2 Beak JY, Kang HS, Kim YS. et al. Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1). Nucleic Acids Res 2008; 36: 1690-1702
• 3 Senée V, Chelala C, Duchatelet S. et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 2006; 38: 682-687
• 4 Dimitri P, Warner JT, Minton JA. et al. Novel GLIS3 mutations demonstrate an extended multisystem phenotype. Eur J Endocrinol 2011; 164: 437-443
• 5 Dimitri P, Habeb AM, Gurbuz F. et al. Expanding the Clinical Spectrum Associated With GLIS3 Mutations. J Clin Endocrinol Metab 2015; 100: E1362-1369
• 6 Nutt RJ, Dowlut MS, McLoone SF. et al. Epidemiology and long-term outcomes of primary congenital glaucoma: a population-based study. Eye (Lond) 2023; 37: 2673-2678
• 7 Anderson D. The development of the trabecular meshwork and its abnormality in primary infantile glaucoma. Trans Am Ophthalmol Soc 1981; 79: 458
• 8 Ling C, Zhang D, Zhang J. et al. Updates on the molecular genetics of primary congenital glaucoma (Review). Exp Ther Med 2020; 20: 968-977
• 9 Almhmoudi F, Abudawood G, Khan A. et al. Congenital glaucoma associated with high hyperopia, an ophthalmic phenotypical manifestation for GLIS3 deletion: case report and review of literature. Ophthalmic Genet 2025;
• 10 Papadopoulos M, Cable N, Rahi J. et al. The British infantile and childhood glaucoma (BIG) eye study. Invest Ophthalmol Vis Sci 2007; 48: 4100-4106